Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-20-030837

Senior VP, Chief Legal Officer sold 13,741 shares at $6.23 ($85,606)

  • Senior VP, Chief Legal Officer acquired 13,741 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Barnes Alane P · Senior VP, Chief Legal Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-04 Exercise or conversion : show line 1 in the form +13,741 $4.15 $57,025 121,802 D
2020-12-04 Sale : show line 2 in the form −13,741 $6.23 $85,606 108,061 D
Open-market sales · 13,741 sh · avg $6.23 · $85,606

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-12-04 Exercise or conversion : show line 3 in the form Emp. Stock Option (Right to Buy) −13,741 13,741 D
Loading xslF345X03/form4.xml…